Gene · 6652
Papers2,028
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,028
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An Arylbenzofuran, Stilbene Dimers, and Prenylated Diels-Alder Adducts as Potent Diabetic Inhibitors from Morus bombycis Leaves. | Antioxidants (Basel) | 2023 | 37107213 | PubTator, text mining | PubMed |
| Response of a Human Lens Epithelial Cell Line to Hyperglycemic and Oxidative Stress: The Role of Aldose Reductase. | Antioxidants (Basel) | 2023 | 37107204 | PubTator, text mining | PubMed |
| An inducible Komagataella phaffii system for protein expression using sorbitol dehydrogenase promoter. | Biotechnol Lett | 2023 | 37074552 | PubTator, text mining | PubMed |
| Current Approach to the Pathogenesis of Diabetic Cataracts. | Int J Mol Sci | 2023 | 37047290 | PubTator, text mining | PubMed |
| Elucidating glial responses to products of diabetes-associated systemic dyshomeostasis. | Prog Retin Eye Res | 2023 | 37028118 | PubTator, text mining | PubMed |
| Sorbitol reduction via govorestat ameliorates synaptic dysfunction and neurodegeneration in sorbitol dehydrogenase deficiency. | JCI Insight | 2023 | 37014713 | PubTator, text mining | PubMed |
| Food Selectivity, Rash, and Leg Pain in a 7-year-old Boy with Malnutrition. | Pediatr Rev | 2023 | 37002358 | PubTator, text mining | PubMed |
| Involvement of Intracellular TAGE and the TAGE-RAGE-ROS Axis in the Onset and Progression of NAFLD/NASH. | Antioxidants (Basel) | 2023 | 36978995 | PubTator, text mining | PubMed |
| Diabetic foot ulcer: A comprehensive review of pathophysiology and management modalities. | World J Clin Cases | 2023 | 36970004 | PubTator, text mining | PubMed |
| SORD-related peripheral neuropathy in a French and Swiss cohort: Clinical features, genetic analyses, and sorbitol dosages. | Eur J Neurol | 2023 | 36943151 | PubTator, text mining | PubMed |
| Molecular Genetics of Abnormal Redox Homeostasis in Type 2 Diabetes Mellitus. | Int J Mol Sci | 2023 | 36902173 | PubTator, text mining | PubMed |
| Mass Spectrometry-Based Untargeted Approaches to Reveal Diagnostic Signatures of Male Infertility in Seminal Plasma: A New Laboratory Perspective for the Clinical Management of Infertility? | Int J Mol Sci | 2023 | 36901856 | PubTator, text mining | PubMed |
| An extensive evaluation of hepatic markers of damage and regeneration in controlled and uncontrolled donation after circulatory death. | Liver Transpl | 2023 | 36879554 | PubTator, text mining | PubMed |
| Increased retinoic acid signaling decreases lung metastasis in salivary adenoid cystic carcinoma by inhibiting the noncanonical Notch1 pathway. | Exp Mol Med | 2023 | 36879115 | PubTator, text mining | PubMed |
| New insight of metabolomics in ocular diseases in the context of 3P medicine. | EPMA J | 2023 | 36866159 | PubTator, text mining | PubMed |
| Bioinformatics-based analysis of the roles of sex hormone receptors in endometriosis development. | Int J Med Sci | 2023 | 36860677 | PubTator, text mining | PubMed |
| The Mechanism of Hyperglycemia-Induced Renal Cell Injury in Diabetic Nephropathy Disease: An Update. | Life (Basel) | 2023 | 36836895 | PubTator, text mining | PubMed |
| In Vitro Antiglycation Potential of Erva-Baleeira (Varronia curassavica Jacq.). | Antioxidants (Basel) | 2023 | 36830081 | PubTator, text mining | PubMed |
| The interaction between polyphyllin I and SQLE protein induces hepatotoxicity through SREBP-2/HMGCR/SQLE/LSS pathway. | J Pharm Anal | 2023 | 36820075 | PubTator, text mining | PubMed |
| Deciphering the underlying mechanism of liver diseases through utilization of multicellular hepatic spheroid models. | BMB Rep | 2023 | 36814078 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6652/papers?page=8